There were 1,892 press releases posted in the last 24 hours and 358,618 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Amydis Announces Successful Completion of Pre-IND Meeting with the FDA for the Development of a First-in-Class Retinal Tracer for the Diagnosis of Alpha-synucleinopathies

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image